1Van Gelder I C, Groenveveld H F, Crijins H J, et al. Lenient versus strict rate in patients with atrial fibrillation[J]N Engl Med, 2010,362 : 1363- 1373.
2Piccini J P, Lopes R D, Kong M H, et al. Pulmonary vein isolation for the maintenance of sinus rhythm in patients with atrial fibrillation., a meta--analysis of randomized controlled trials[J]. Circ Atrhythm Electrophysiol, 2009,2 : 626- 633.
3Pappone C, SantenelIi V, Managuso F,et al. Pulmonary Vein denervation enhances long term benefit after circumferential ablation for paroxysmal atrial fibrillation [J]Circulation, 2004,109 : 327- 334.
4Calkins H, Reynolds M R, Spector P, et al. Treatment of atrial fibrillation with antiarrhythmic drugs or radiofrequency ablation two systematic literature reviews and meta--analyses[J] Circ ar rhythm Electrophysiol, 2009,2:349 - 361.
5Haissaguerre M, Sanders P, Hocini M, et al. pulmonary veins in the substrate for atrial fibrillation: the "venous wave" hypothesis IJJ[J] J Am coll cardiol, 2004,43:2290-2292.
6Canun A J, Kirchhof P, Lip G Y, et al. Guide Lines for the management of atrial fibrillation: The Tesk Force for the management of the European Society of cardiology(ESC) [J]. Eur Heart J, 2010,31(19):2369--2429.
7Warfarin Versus Aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fi brillation Treatment of the aged study, BAFTA): a randomized Controlled trial IJJ[J]. Lancet, 2007,370 : 9586-9588.
8Khoo C W, Lip G Y. Insights from the dabigatran versus warfarin in patients with atrial fibrillation (RE--LY)trial [J]. Expert Opin Pharm acother,2010,11: 685-687.
9Hass S. New oral X a and II a inhibitors : updates on clinical trial re suits [J]. J thromb Thrombolysis, 2008,25:52 -60.
10Sick P B, Schuler G, Hauptmann K E,et al. Initial worldwide experience with the WATCHMAN left atrial appendage system for stroke prevention in atrial fibrillation [J]. J Am coll cardiol, 2007, 49(13):1491--1495.
